The Claim
Creatine monohydrate supplementation at 5 g/day for 8 weeks, when combined with escitalopram, significantly improves depressive symptoms in adults with major depressive disorder, with a Cohen's d of 1.13 and a 52% remission rate compared to a 25.9% remission rate with placebo and escitalopram.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with major depressive disorder, taking 5 grams of creatine monohydrate daily for 8 weeks along with escitalopram results in a 52% remission rate, compared to a 25.9% remission rate with escitalopram and a placebo.
See the scientific wording
Creatine monohydrate supplementation at 5 g/day for 8 weeks, when combined with escitalopram, significantly improves depressive symptoms in adults with major depressive disorder, with a Cohen's d of 1.13 and 52% remission rate compared to 25.9% with placebo and escitalopram, suggesting it may enhance antidepressant response in this specific population.
Creatine enters the brain and gets converted into a high-energy storage molecule that quickly replenishes the brain's main fuel when neurons need it most. This extra energy helps neurons in mood-controlling areas work better, survive longer, and communicate more effectively, which reduces symptoms of depression.
What the research says
1 studyTaking 5 grams of creatine daily for 8 weeks along with the antidepressant escitalopram helped more adults with depression feel significantly better than taking the antidepressant alone — over half improved, compared to just a quarter on placebo.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.